Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03729245
Brief Title: A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)

First Submitted : October 29, 2018
First Submitted that Met QC Criteria : October 31, 2018
First Posted : November 2, 2018

Last Update Submitted that Met QC Criteria : April 19, 2021
Last Update Posted : April 21, 2021